9:06AM ET 6/22/2022 MT NewswiresRhythm Pharmaceuticals (RYTM) said Wednesday that it has launched weight-loss drug Imcivree in Germany. Imcivree received European Commission approval last...
8:39AM ET 6/22/2022 MT NewswiresRhythm Pharmaceuticals (RYTM) said Wednesday the European Commission approved the expansion of the dosing regimen for its Imcivree drug. The approval...
8:54AM ET 6/17/2022 MT NewswiresRhythm Pharmaceuticals (RYTM) has an average rating of outperform and price targets ranging from $4 to $40, according to analysts polled by Capital IQ. (MT...
7:33AM ET 6/17/2022 MT NewswiresRhythm Pharmaceuticals (RYTM) has an average rating of outperform and price targets ranging from $4 to $40, according to analysts polled by Capital IQ. (MT...